| Literature DB >> 35646495 |
William J Rifkin1, Isabel S Robinson1, Carmen Kloer1, Courtney N Cripps1, Carter J Boyd1, Gaines Blasdel2, Lee C Zhao1,2, Rachel Bluebond-Langner1,2.
Abstract
Background: Gender-affirming mastectomy has become one of the most frequently performed procedures for transgender and nonbinary patients. Although there are a variety of potential surgical approaches available, the impact of technique on outcomes remains unclear. Here we present our experience performing periareolar and double incision mastectomies, with a focus on comparing patient demographics, preoperative risk factors, and surgical outcomes and complication rates between techniques.Entities:
Year: 2022 PMID: 35646495 PMCID: PMC9132529 DOI: 10.1097/GOX.0000000000004356
Source DB: PubMed Journal: Plast Reconstr Surg Glob Open ISSN: 2169-7574
Fig. 1.Preoperative markings for double-incision mastectomy. The patient is marked in the standing position, with arms raised to help accentuate the inferior and lateral borders of the pectoralis muscle. The superior incision is marked straight across the inferior border of the pectoralis major and is angled superiorly toward the axilla to follow the inferolateral border of the pectoralis muscle. Reprinted with permission from Plast Reconstr Surg 2021;147:1288–1296.
Fig. 2.The inferior incision is placed in the inferior pectoral shadow and not in the inframammary fold, which is often lower than the pectoral shadow. This is marked intraoperatively while pulling the breast parenchyma and skin flap superiorly on tension to estimate the closure. Reprinted with permission from Plast Reconstr Surg 2021;147:1288–1296.
Fig. 3.Preoperative (A) and postoperative (B) photographs of a patient who underwent gender-affirming mastectomy with a periareolar technique.
Fig. 4.Preoperative (A) and postoperative (B) photographs of a patient who underwent gender-affirming mastectomy with a double incision and free nipple graft technique.
Patient Demographics and Preoperative Risk Factors
| Periareolar | Double Incision |
| |
|---|---|---|---|
| Patients | 96 | 390 | |
| Mean age, y | 22.6 | 26.3 |
|
| Mean BMI, kg/m2 | 22.1 | 26.6 |
|
| Mean OR time, min | 130 | 106 |
|
| Mean transition time, mo | 47.4 | 56.5 | 0.20 |
| Testosterone use (%) | 93 (96.9) | 295 (75.8) |
|
| Mean testosterone duration, mo | 26.8 | 24.5 | 0.27 |
| Fischer grade (%) |
| ||
| 1 | 3 (3.1) | 0 (0) | |
| 2A | 56 (58.3) | 2 (0.5) | |
| 2B | 37 (38.5) | 73 (19.0) | |
| 3 | 0 (0) | 304 (79.0) | |
| 4 | 0 (0) | 6 (1.6) | |
| Mean specimen weight, g | 154.6 | 642.1 |
|
| Preoperative risk factors (%) | |||
| Diabetes | 0 (0) | 7 (1.8) | 0.19 |
| Coagulopathy | 1 (1) | 6 (1.5) | 0.71 |
| Cardiovascular comorbidity | 4 (4.2) | 16 (4.1) | 0.99 |
| Recent nicotine use | 6 (6.3) | 41 (10.5) | 0.21 |
| Former smoker | 8 (8.3) | 67 (17.2) |
|
Bold values indicate statistical significance.
*Includes history of venous thromboembolism, pulmonary embolus, transient ischemic attack, cerebrovascular accident, malignancy, autoimmune disease, and primary coagulopathy.
‡Includes hypertension, hyperlipidemia, coronary artery disease, arrhythmia, cardiomyopathy, and heart failure.
Postoperative Complications and Management
| Periareolar | Double Incision |
| |
|---|---|---|---|
| Hematoma (%) | 3 (3.1) | 22 (5.6) | 0.90 |
| Hematoma requiring intervention | 1 (1) | 13 (3.3) | 0.32 |
| Seroma (%) | 32 (33.3) | 142 (36.4) | 0.51 |
| Seroma requiring intervention | 1 (1) | 2 (0.5) | 0.48 |
| Surgical site infection (%) | 1 (1) | 5 (1.3) | 0.99 |
| NAC necrosis (%) | 0 (0) | 0 (0) | 0.99 |
| Revision procedure performed (%) | 14 (14.6) | 62 (15.8) | 0.83 |
| Mean no. of revision procedures | 1.3 | 1.2 | 0.47 |
Multivariate Regression Analysis of Outcomes
| Hematoma | Seroma | SSI | NAC Necrosis | Revision | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Variable | β | 95% CI |
| β | 95% CI |
| β | 95% CI |
| β | 95% CI |
| β | 95% CI |
|
| Age | –0.01 | 0.90–1.08 | 0.77 | –0.06 | 0.71–1.24 | 0.66 | –0.001 | 0.99–1.01 | 0.68 | –0.003 | 0.99–1.01 | 0.51 | –0.08 | 0.75–1.14 | 0.46 |
| BMI | –0.07 | 0.81–1.08 | 0.33 | 0.44 | 0.77–1.41 | 0.77 | 0.04 | 0.96–1.13 | 0.32 | 0.002 | 0.87–1.16 | 0.98 | –1.08 | 0.05–2.55 | 0.29 |
| Operative time | 0.001 | 0.97–1.04 | 0.97 | –0.005 | 0.93–1.06 | 0.89 | 0.13 | 1.00–1.28 | 0.04 | 0.004 | 0.81–1.25 | 0.97 | –0.41 | 0.20–2.16 | 0.50 |
| Diabetes | — | — | 0.99 | — | — | 0.99 | — | — | 0.99 | — | — | 0.99 | — | — | 0.99 |
| Recent nicotine | — | — | 0.99 | — | — | 0.99 | — | — | 0.99 | — | — | 0.99 | — | — | 0.99 |
| Former smoker | — | — | 0.99 | — | — | 0.99 | |||||||||
| Cardiovascular comorbidities | — | — | 0.99 | — | –2.84 | 0.003–1.14 | 0.06 | — | — | — | — | — | — | — | — |
| Mastectomy type | –1.14 | 0.03–3.47 | 0.35 | 1.54 | 0.09–253.1 | 0.45 | 0.99 | 0.26–28.1 | 0.41 | 0.80 | 0.20–25.2 | 0.52 | — | — | 0.99 |
| Case number | 0.002 | 0.99–1.01 | 0.38 | 0.001 | 0.99–1.01 | 0.86 | 1.15 | 0.27–37.5 | 0.36 | — | — | 0.99 | — | — | 0.99 |
SSI, surgical site infection; CI, confidence interval.